| ContactSitemapDisclaimerImpressumDeutschEnglish | ||||||
INSTAND e.V.Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien e.V. |
||||||
| PublicationsPublications | ||||||
| NewsAbout INSTAND e.V.Reference laboratoryEQASPublicationsEventsPromoting PrizeAbout usLinks | Patricia Kaiser, Theodorus Akerboom, Rüdiger Ohlendorf and Hans Reinauer „Liquid Chromatography-Isotope Dilution-Mass Spectrometry as a New Basis for the Reference Measurement Procedure for Hemoglobin A1c Determination“ Clinical Chemistry 56:5 750-754 (2010)
Patricia Kaiser, Theodorus Akerboom, Petra Molnar and Hans Reinauer „Modified HPLC-Electrospray Ionization/Mass Spectrometry Method for HbA1c Based on IFCC Reference measurement Procedure“ Clinical Chemistry 54:6 1018-1022 (2008)
Kaiser, P., Akerboom, T. Dux, L., Reinauer, H. Modification of the IFCC reference measurement procedure for determination of HbA1c by HPLC-ESI-MS. Ger.Med.Sci.4: Doc06 (2006)
Vacata, V., Jahns-Streubel, G., Baldus, M., Wood, W.G. Practical solution for the control of the pre-analytical phase in decentralised clinical laboratories for meeting requirements of the medical laboratory accreditation standard ISO 15189. Clin. Lab. In Print.
Bewarder, N., Abmeier, F., Bergmann, S., Drohla, S., Drescher, V., Gerstmeyer, A., Kuß, S., Melamies, L., Miksch, R., Ortin, V., Neumeister, V., Odarjuk, J., Stratmann, M.M., Weinhold, A., Wiesner, B., Wildbrett, D.A., Wollenberg, P., Zinsmeyer, J., Zogbaum. M., Zwerenz, P., Zwirner, M., Wood, W.G. Multicentre evaluation of performance of C-reactive protein analysis over a one-year period. Clin. Lab. In Print.
Wood, W.G. Problems with the external quality assessment of accuracy of point of care devices (POCD) for blood glucose are independent of sample composition. Clin. Lab. 52, (2006) in print (July 2006)
Kaiser, P., Akerboom, T., Wood, W.G., Reinauer, H. A new approach for the determination of immunosuppressive drugs using HPLC-MS/MS and Cs+ adducts. Ger. Med. Sci. 2006;4:Doc01 [electronic publishing – January 2006]
Kaiser, P., Akerboom, T., Wood, W.G., Reinauer, H. A novel LC-IDMS/MS method for the determination of the cardiac glycosides digoxin and digitoxin using caesium adducts. Clin. Lab. 52, 37-42 (2006)
Lüdemann, J., Schminke, U., Berger, K., Alte, D., Mitusch, R., Wood, W.G., Jaschinski. A., Barnow, S., John, U., Kessler, C., Nauck, M. Association between alcohol consumption, laboratory markers and subclinical carotid atherosclerosis. The study of health in Pomerania. Clin. Chem. Lab. Med. 43, A 72, (2005)
Schminke, U., Lüdemann, J., Berger, K., Jaschinski, A., Mitusch, R., Wood, W.G., John, U., Kessler, C. The association between alcohol consumption and subclinical carotid atherosclerosis. The Study of Health in Pomerania. Stroke 36, 1746-1752 (2005)
Wood, W.G. The preanalytical phase – Can the requirements of the DIN-EN-ISO 15189 be met practically for all laboratories? A view of the “German situation”. Clin. Lab. 51, 665-671 (2005)
Wood, W.G. Some practical thoughts on restructuring the current guideline of the Federal Medical Council (Richtlinie der Bundesärztekammer [RiliBÄK]) in Germany for quality control in clinical laboratory analysis based on results from external quality assesment surveys. Clin. Lab. 51, 547-573 (2005)
Mitusch, R., Lüdemann, J., Wood, W.G., Berger, K., Schminke, U., Suter, M., Kessler, C., John, U., Rupp, J., Kentsch, M., Maass, M. Asymptomatic carotid atherosclerosis is associated with circulating Chlamydia pneumoniae DNA in younger normotensive subjects in a general population survey. Arteriosclerosis, Thrombosis and Vascular Biology, 25, 386-391 (2005).
Reinauer, H., Wood, W.G. External quality assessment of tumour marker analysis – The state of the art and consequences for estimating diagnostic sensitivity and specificity. Ger Med. Sci. (2005) 3: Doc 02 [electronic publishing – 2005-05-31]
Wood, W.G. Questionable results – who directs the EQAS organisers Clin. Chem. Lab. Med. 42, 1079 (2004)
Wood, W.G., Singer, J., Schmidt-Gayk, H. Establishment of reference intervals for enzyme catalytic activity concentration measurements at 37 °C – a practical approach. Clin. Lab. 50, 455-475 (2004)
Wood, W.G., Kramer, U. Correction to the IFCC primary reference method for the measurement of catalytical activity concentration of enzymes at 37 °C – part 2: reference procedure for the measurement of creatine kinase – Letter to the Editor. Clin. Chem. Lab. Med. 42, 353 (2004)
Wood, W.G., Hanke, R. Comparability of method results and performance in a national external quality assessment scheme between 1993 and 2003 using thyroid associated antibodies as examples. Clin. Lab. 50, 209-222 (2004)
Appel, W. et al. (Working group of DDG: Appel, Briehl, Brüggemann, da Fonseca-Wollheim, Fischbach, Köppen, Mayer-Lüerßen, Rodt, von Rücker, Warlo, Wood) The concept of good laboratory diagnosing practice ("Gute Labordiagnostische Praxis GLDP") Clin. Lab. 45, 569-580, (1999)
Wood, W.G., Hanke, R., Reinauer, H. Comparability of method results and performance in a national external quality assessment scheme between 1993 and 2003 using thyroid associated analytes as examples. Clin. Lab. 50, 333-346 (2004)
Kaiser, P., Kramer, U., Meißner, D., Kress, M., Wood, W.G., Reinauer, H. Determination of the cardiac glycosides digoxin and digitoxin by liquid chromatography combined with isotope dilution mass spectrometry (LC-IDMS) – a candidate reference measurement procedure. Clin. Lab. 49, 329-343, (2003)
Wood, W.G., Hanke, R., Meißner, D., Reinauer, H. Experience with an external quality assessment programme for point-of-care-testing (POCT) devices for the determination of blood glucose. Clin. Lab. 49, 151-159, (2003)
Wood, W.G. When should BSG or CRP be determined? ("Wann sollte BSG oder CRP bestimmt werden?") Dtsch. Med. Wochenschr. 127, 2527-2528, (2002)
Kress, M., Meißner, D., Kaiser, P., Wood, W.G. How to make things work again – troubleshooting using the GC-IDMS determination of triacylglycerols as an example. Clin. Lab. 48, 635-646, (2002)
Kress, M., Meißner, D., Kaiser, P., Hanke, R., Wood, W.G. Determination of theophylline by HPLC and GC-IDMS, the effect of chemically similar xanthine derivatives on the specificity of the method and the possibility of paracetamol as an interfering substance. Clin. Lab. 48, 541-551, (2002)
Kress, M., Meißner, D., Kaiser, P., Hanke, R., Wood, W.G. The measurement of theophylline in human serum or plasma using gas chromatography and isotope-dilution mass-spectrometry (GC-IDMS) taking other substituted xanthines into consideration. Clin. Lab. 48, 535-540, (2002)
Wood, W.G. Mistakes in determining tumor markers ("Fehler bei der Bestimmung von Tumormarkern") Dtsch. Med. Wochenschr. 127, 577, (2002)
1. Wood, W.G., Kress, M., Meißner, D., Hanke, R., Reinauer, H. The determination of free and protein-bound haemoglobin in plasma using a combination of HPLC and absorption spectrometry. Clin. Lab. 47, 279-288, (2001)
|
![]() 30.01.2012 Final evaluation of the EQAS Virology November/December 2011As to the following EQA schemes:
23.12.2011 Information and pre-evaluation of virology EQASs November/December 2011Pre-evaluation of virology EQASs November/December 2011 is now available =>here.
09.12.2011 Bacteriology No. 411 from November 2011Here you will find the results of Bacteriology No. 411 from November 2011:[more] 09.12.2011 EQA schemes Bacteriology No. 411 and 412Here you will find important informations in 2012 for the EQA schemes Bacteriology No. 411 and 412:[more] |
||||
|
INSTAND e.V. - Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien e.V. (vormals Hämometerprüfstelle) D-40223 Düsseldorf - Ubierstr. 20 - Postfach 250211 - Tel +49 211 159213 0 FAX +49 211 159213 30 WHO Collaborating Centre for Quality Assurance and Standardization in Laboratory Medicine |
||||||